Trial Profile
CID 0805 - Treatment of Acute HIV Infection With a Once Daily Regimen of Emtricitabine, Tenofovir and Efavirenz - A Pilot Study of Response to Therapy and HIV Pathogenesis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 04 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.